Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical impact of molecular biomarkers in gliomas.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia - 1 Mar 2015

Siegal Tali

Abstract excerpt

The World Health Organization (WHO) classification system for glial tumors provides guidance as to the predicted course of the disease and choice of treatment. However, histologically identical tumors may have a very different outcome and response to treatment. Molecular markers that carry both diagnostic and prognostic information add valuable tools by redefining tumor subtypes within each WHO category....

Topics

Join the communities discussing this publication.

Astrocytoma
Chromosomes, Human, Pair 19
DNA Helicases
DNA Modification Methylases
DNA Repair Enzymes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Isocitrate Dehydrogenase

Oligodendroglioma

X-linked Nuclear Protein

Source

Identifiers

PMID: 25533211
DOI: 10.1016/j.jocn.2014.10.004

Genes

ATRX
BRAF
EGFR
MGMT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical impact of molecular biomarkers in gliomas.PMID 25533211Read ↗

Predictive and Prognostic Significance of Molecular Biomarkers in GlioblastomaSemantic proximity Read ↗

Molecular pathology in adult high‐grade gliomas: from molecular diagnostics to target therapiesSemantic proximity Read ↗

Prognostic and Predictive Biomarkers in Gliomas.Semantic proximity Read ↗

Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.Semantic proximity Read ↗

Predictive biomarkers in adult gliomas: the present and the future.Semantic proximity Read ↗

Molecular neuro-oncology in clinical practice: a new horizon.Semantic proximity Read ↗

Molecular biology of high-grade gliomas: what should the clinician know?Semantic proximity Read ↗

Perspectives of Personalized Chemotherapy of Gliomas Based on Molecular Tumor Profiling.Semantic proximity Read ↗

A practical review of prognostic correlations of molecular biomarkers in glioblastomaSemantic proximity Read ↗

Role of Molecular Pathology in the Treatment of Anaplastic Gliomas and Glioblastomas.Semantic proximity Read ↗

Diagnostic and prognostic markers in gliomas - an update.Semantic proximity Read ↗

Updates in prognostic markers for gliomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.